Bioburden Testing Market worth $565.6M by 2019, According to a New Study on ASDReports

Wednesday 20 May 2015, Amsterdam

Market Research Report Press Release The report, now available on ASDReports, "Bioburden Testing Market by Product (Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)), Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the bioburden testing market along with estimates and forecasts of the revenue and share analysis.

The report segments the bioburden testing market on the basis of products and services, test types, applications, end users, and regions. In the product segment, consumables accounted for the largest share in 2014; however, the culture media and reagents & kits segment will grow at the highest CAGR during the forecast period as culture media and reagents & kits are most commonly used for bioburden testing. Factors such as the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the bioburden testing market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination are driving the growth of the bioburden testing market.

Based on regions, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in the forecast period.

Key players in the bioburden testing market include Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co. Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.).
Bioburden Testing Market - Forecast to 2019

Bioburden Testing Market - Forecast to 2019

Publish date : May 2015
Report code : ASDR-198657
Pages : 146 Media contact: S. Koopman - Marketing and Communications / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E :

 back to News